Skip to main content
RDGL
OTC Life Sciences

VIVOS INC Reports $1.19M Q1 Net Loss, Signaling Continued Financial Strain

Tom Rudovsky · Reported by Wiseek News
More coverage: Industrial
Sentiment info
Negative
Importance info
8
Price
$0.068
Mkt Cap
$32.726M
52W Low
$0.043
52W High
$0.155
52W Position info
60% above low
Off High info
56% below high
Rel. Volume info
0.3× avg
Market data snapshot near publication time

RDGL sits 60% above its 52-week low of $0.043 on light trading volume (0.3× avg).

Summary

VIVOS INC reported Q1 2026 revenue of $36.1K, a 35% increase year-over-year, but its net loss significantly widened to $1.19 million from $834.7K in Q1 2025. This continued financial underperformance reinforces the "critical financial distress" and "going concern warning" highlighted in the recent 10-K, which also noted a recent $1.55 million dilutive offering. The substantial quarterly loss indicates a high cash burn rate relative to the company's size. Despite some operational progress like increased IsoPet adoption and regulatory advancements, the widening net loss and extremely low revenue raise significant concerns about the company's long-term financial viability and its ability to sustain operations without further dilutive financing. Investors will be closely watching for signs of improved profitability, reduced cash burn, and the successful execution of its channel and pricing strategies to convert operational traction into sustainable revenue and reduced losses.

At the time of this announcement, RDGL was trading at $0.07 on OTC in the Life Sciences sector, with a market capitalization of approximately $32.7M. The 52-week trading range was $0.04 to $0.15. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

RDGL - Latest Insights

RDGL
Nov 09, 2026, 4:31 PM EST
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $0.0428
Real-time Price: $0.04407 info
Change: +$0.00127 (+3%) info
Market Cap: $21.78M info
RDGL
Nov 05, 2026, 8:54 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.042
Real-time Price: $0.04407 info
Change: +$0.00207 (+5%) info
Market Cap: $21.78M info
RDGL
Oct 08, 2026, 4:46 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.045885
Real-time Price: $0.04407 info
Change: -$0.001815 (-4%) info
Market Cap: $21.78M info
RDGL
Oct 05, 2026, 5:26 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.0431
Real-time Price: $0.04407 info
Change: +$0.00097 (+2%) info
Market Cap: $21.78M info
RDGL
Oct 01, 2026, 5:15 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $0.04981
Real-time Price: $0.04407 info
Change: -$0.00574 (-12%) info
Market Cap: $21.78M info